Outcomes of chronic myeloid leukemia patients after therapeutic failure to conventional tyrosine kinase inhibitors and asciminib. - Pérez-Lamas L; Díaz AS; Casterá EM; Soto MH; Coll AP; De Las Heras N; Cortes M; Tenza PV; Pacho MS; Magan AS; Angona A; Cervero C; et al. (Annals of hematology, 2024)